Mayne Pharma Group Limited
Символ: MYX.AX
ASX
6.8
AUDПазарна цена днес
-2.3362
Съотношение P/E
0.0191
Коефициент PEG
578.51M
MRK Cap
- 0.00%
Доходност на DIV
Mayne Pharma Group Limited (MYX-AX) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 611.09 | 229.2 | 97.1 | 98.4 | |||||||||||||||||
balance-sheet.row.short-term-investments | 128.86 | 127.5 | 1.3 | 0 | |||||||||||||||||
balance-sheet.row.net-receivables | 952.3 | 209.5 | 283 | 193.3 | |||||||||||||||||
balance-sheet.row.inventory | 408.83 | 82.7 | 108.9 | 102.5 | |||||||||||||||||
balance-sheet.row.other-current-assets | 163.02 | 32.2 | 22.6 | 22.3 | |||||||||||||||||
balance-sheet.row.total-current-assets | 2135.24 | 553.6 | 511.6 | 416.5 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 377.83 | 51.5 | 225.9 | 221.6 | |||||||||||||||||
balance-sheet.row.goodwill | 22.13 | 0 | 22.1 | 20.3 | |||||||||||||||||
balance-sheet.row.intangible-assets | 1779.31 | 617.3 | 427.5 | 636.2 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 1801.43 | 617.3 | 449.6 | 656.5 | |||||||||||||||||
balance-sheet.row.long-term-investments | -22.13 | 0 | -22.1 | -20.3 | |||||||||||||||||
balance-sheet.row.tax-assets | 296.63 | 23.4 | 133.7 | 187.2 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 609.67 | 2.3 | 4.5 | 16.7 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 3063.44 | 694.5 | 791.5 | 1061.6 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 5198.68 | 1248.1 | 1303.1 | 1478.1 | |||||||||||||||||
balance-sheet.row.account-payables | 188.01 | 32 | 63.6 | 42.4 | |||||||||||||||||
balance-sheet.row.short-term-debt | 502.78 | 14.4 | 408 | 54 | |||||||||||||||||
balance-sheet.row.tax-payables | 2.39 | 0 | 1.2 | 0 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 64.17 | 28.5 | 5.7 | 285.8 | |||||||||||||||||
Deferred Revenue Non Current | 10.32 | 4.6 | 0 | 7 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 44.94 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 872.5 | 256.9 | 156.9 | 125.9 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 1035.3 | 302.8 | 135.6 | 484 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 17.7 | 4.6 | 5.7 | 7 | |||||||||||||||||
balance-sheet.row.total-liab | 2661.23 | 613.8 | 764.9 | 706.6 | |||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 4934.69 | 1233.7 | 1238.5 | 1238.5 | |||||||||||||||||
balance-sheet.row.retained-earnings | -3029.5 | -769.8 | -840.3 | -559.1 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 639.91 | 170.4 | 147.7 | 88.9 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 2545.1 | 634.4 | 545.9 | 768.4 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 5198.68 | 1248.1 | 1303.1 | 1478.1 | |||||||||||||||||
balance-sheet.row.minority-interest | -7.65 | 0 | -7.7 | 3.2 | |||||||||||||||||
balance-sheet.row.total-equity | 2537.45 | 634.4 | 538.2 | 771.6 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 5198.68 | - | - | - | |||||||||||||||||
Total Investments | 128.86 | 127.5 | 1.3 | -20.3 | |||||||||||||||||
balance-sheet.row.total-debt | 578.98 | 47.5 | 413.7 | 346.8 | |||||||||||||||||
balance-sheet.row.net-debt | 95.42 | -54.2 | 316.6 | 248.5 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -600.87 | -317.4 | -209.5 | -208.4 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 140.71 | 65.4 | 55.2 | 68.2 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 122.22 | 50 | 63.4 | -43.9 | |||||||||||||||||
cash-flows.row.stock-based-compensation | -69.27 | 6.8 | 4.6 | 7.7 | |||||||||||||||||
cash-flows.row.change-in-working-capital | 117.09 | 145.4 | -8.9 | -13.6 | |||||||||||||||||
cash-flows.row.account-receivables | 75.71 | 118.7 | -66.1 | -3.2 | |||||||||||||||||
cash-flows.row.inventory | -2.89 | -12.1 | -2.4 | -25.9 | |||||||||||||||||
cash-flows.row.account-payables | 60.04 | 45.3 | 60.7 | 16.4 | |||||||||||||||||
cash-flows.row.other-working-capital | -15.77 | -6.5 | -1.1 | -0.9 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 209.75 | 6.6 | 78.6 | 237.3 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -80.37 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -242.03 | -219.6 | -11.9 | -25.1 | |||||||||||||||||
cash-flows.row.acquisitions-net | 842.23 | 842.2 | 5.2 | 0 | |||||||||||||||||
cash-flows.row.purchases-of-investments | -127.53 | -127.5 | 0 | 0 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 91.63 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.other-investing-activites | -39.52 | -21.6 | -21.8 | -24.1 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 524.77 | 473.5 | -28.5 | -49.2 | |||||||||||||||||
cash-flows.row.debt-repayment | -394.15 | -376 | -39.8 | -25.8 | |||||||||||||||||
cash-flows.row.common-stock-issued | 4.35 | 2.3 | 0 | 0 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | -17.16 | -6.2 | 0 | 0 | |||||||||||||||||
cash-flows.row.dividends-paid | -45.29 | -45.3 | 0 | 0 | |||||||||||||||||
cash-flows.row.other-financing-activites | 2.73 | -6.2 | 76.8 | -3 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -449.51 | -431.5 | 37 | -28.8 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -9.49 | -2.9 | 6.8 | -9 | |||||||||||||||||
cash-flows.row.net-change-in-cash | -5.51 | 4.6 | -1.3 | -39.8 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 483.56 | 101.7 | 97.1 | 98.4 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 489.07 | 97.1 | 98.4 | 138.2 | |||||||||||||||||
cash-flows.row.operating-cash-flow | -80.37 | -43.1 | -16.6 | 47.3 | |||||||||||||||||
cash-flows.row.capital-expenditure | -242.03 | -219.6 | -11.9 | -25.1 | |||||||||||||||||
cash-flows.row.free-cash-flow | -322.4 | -262.7 | -28.5 | 22.2 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 599.87 | 183.6 | 157.1 | 400.8 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 448.54 | 156.7 | 133.4 | 273.8 | |||||||||||||||||
income-statement-row.row.gross-profit | 151.33 | 26.8 | 23.7 | 127 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 32.72 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 159.26 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 171.82 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | 0 | 12.6 | 74.4 | 6.4 | |||||||||||||||||
income-statement-row.row.operating-expenses | 414.72 | 213.3 | 145.6 | 125.7 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 863.26 | 370 | 279 | 399.4 | |||||||||||||||||
income-statement-row.row.interest-income | 10.88 | 6.7 | 0.5 | 0.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 18.98 | 10.5 | 11.5 | 13.3 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 171.82 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -235.29 | -83.3 | -23.7 | -265.3 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 12.6 | 74.4 | 6.4 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | -235.29 | -83.3 | -23.7 | -265.3 | |||||||||||||||||
income-statement-row.row.interest-expense | 18.98 | 10.5 | 11.5 | 13.3 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 140.71 | 65.4 | 55.2 | 68.2 | |||||||||||||||||
income-statement-row.row.ebitda-caps | -122.68 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | -263.39 | -186.4 | -121.9 | 1.4 | |||||||||||||||||
income-statement-row.row.income-before-tax | -498.68 | -269.7 | -145.6 | -263.9 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 112.67 | 47.7 | 74.5 | -54.8 | |||||||||||||||||
income-statement-row.row.net-income | -599.94 | -316.4 | -281.3 | -208.4 |
Често задавани въпроси
Какво е Mayne Pharma Group Limited (MYX.AX) общи активи?
Mayne Pharma Group Limited (MYX.AX) общите активи са 1248134000.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 270347000.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е -0.359.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е -0.359.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е -0.897.
Какъв е общият приход на предприятието?
Общият приход е -0.381.
Каква е Mayne Pharma Group Limited (MYX.AX) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е -316419000.000.
Какъв е общият дълг на фирмата?
Общият дълг е 47505000.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 213282000.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 109227000.000.